Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China; Columbia Center for Human Development, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, People's Republic of China; Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China; Division of Digestive and Liver Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York.
Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China; Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, People's Republic of China; Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.
Gastroenterology. 2023 Jun;164(7):1119-1136.e12. doi: 10.1053/j.gastro.2023.01.037. Epub 2023 Feb 4.
BACKGROUND & AIMS: Transformation of stem/progenitor cells has been associated with tumorigenesis in multiple tissues, but stem cells in the stomach have been hard to localize. We therefore aimed to use a combination of several markers to better target oncogenes to gastric stem cells and understand their behavior in the initial stages of gastric tumorigenesis.
Mouse models of gastric metaplasia and cancer by targeting stem/progenitor cells were generated and analyzed with techniques including reanalysis of single-cell RNA sequencing and immunostaining. Gastric cancer cell organoids were genetically manipulated with clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) for functional studies. Cell division was determined by bromodeoxyuridine-chasing assay and the assessment of the orientation of the mitotic spindles. Gastric tissues from patients were examined by histopathology and immunostaining.
Oncogenic insults lead to expansion of SOX9 progenitor cells in the mouse stomach. Genetic lineage tracing and organoid culture studies show that SOX9 gastric epithelial cells overlap with SOX2 progenitors and include stem cells that can self-renew and differentiate to generate all gastric epithelial cells. Moreover, oncogenic targeting of SOX9SOX2 cells leads to invasive gastric cancer in our novel mouse model (Sox2-CreERT;Sox9-loxp(66)-rtTA-T2A-Flpo-IRES-loxp(71);Kras(Frt-STOP-Frt-G12D);P53), which combines Cre-loxp and Flippase-Frt genetic recombination systems. Sox9 deletion impedes the expansion of gastric progenitor cells and blocks neoplasia after Kras activation. Although Sox9 is not required for maintaining tissue homeostasis where asymmetric division predominates, loss of Sox9 in the setting of Kras activation leads to reduced symmetric cell division and effectively attenuates the Kras-dependent expansion of stem/progenitor cells. Similarly, Sox9 deletion in gastric cancer organoids reduces symmetric cell division, organoid number, and organoid size. In patients with gastric cancer, high levels of SOX9 are associated with recurrence and poor prognosis.
SOX9 marks gastric stem cells and modulates biased symmetric cell division, which appears to be required for the malignant transformation of gastric stem cells.
干细胞/祖细胞的转化与多种组织的肿瘤发生有关,但胃中的干细胞一直难以定位。因此,我们旨在使用多种标记物的组合,更好地将癌基因靶向胃干细胞,并了解它们在胃肿瘤发生的初始阶段的行为。
通过靶向干细胞/祖细胞,生成了胃化生和癌症的小鼠模型,并使用包括单细胞 RNA 测序和免疫染色的再分析在内的技术进行了分析。使用成簇规律间隔短回文重复(CRISPR)/CRISPR 相关蛋白 9(Cas9)对胃癌细胞类器官进行遗传操作,以进行功能研究。通过溴脱氧尿苷追踪测定和有丝分裂纺锤体取向的评估来确定细胞分裂。通过组织病理学和免疫染色检查患者的胃组织。
致癌损伤导致小鼠胃中 SOX9 祖细胞的扩增。遗传谱系追踪和类器官培养研究表明,SOX9 胃上皮细胞与 SOX2 祖细胞重叠,并包括能够自我更新并分化为产生所有胃上皮细胞的干细胞。此外,我们的新型小鼠模型(Sox2-CreERT;Sox9-loxp(66)-rtTA-T2A-Flpo-IRES-loxp(71);Kras(Frt-STOP-Frt-G12D);P53)中,SOX9SOX2 细胞的致癌靶向导致侵袭性胃癌,该模型结合了 Cre-loxp 和 Flippase-Frt 遗传重组系统。Sox9 的缺失阻碍了胃祖细胞的扩增,并阻止了 Kras 激活后的肿瘤发生。尽管 Sox9 不需要维持以不对称分裂为主的组织稳态,但在 Kras 激活的情况下 Sox9 的缺失会导致对称细胞分裂减少,并有效地减弱 Kras 依赖性干细胞/祖细胞的扩增。同样,在胃癌类器官中 Sox9 的缺失会减少对称细胞分裂、类器官数量和类器官大小。在患有胃癌的患者中,高水平的 SOX9 与复发和预后不良有关。
SOX9 标记胃干细胞,并调节偏向性对称细胞分裂,这似乎是胃干细胞恶性转化所必需的。